List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #27,881 to #27,930.
- IL-15 → Interleukin 15
- IL-16 → Interleukin 16
- IL-2 → Interleukin 2
- IL-21 → Interleukin 21
- IL-27 → Interleukin 27
- IL-4 → Interleukin 4
- IL-5 → Interleukin 5
- IL-6 → Interleukin 6
- IL-7 → Interleukin 7
- IL-7 receptor → Interleukin 7
- IL-8 → Interleukin 8
- IL-9 → Interleukin 9
- IL10RB → Interleukin 10 receptor, beta subunit
- IL11RA → Interleukin 11 receptor alpha subunit
- IL12RB1 → Interleukin 12 receptor, beta 1 subunit
- IL12RB2 → Interleukin 12 receptor, beta 2 subunit
- IL15RA → Interleukin 15 receptor, alpha subunit
- IL1R1 → Interleukin 1 receptor, type I
- IL20RA → Interleukin 20 receptor, alpha subunit
- IL21R gene → IL21R
- IL5RA → Interleukin 5 receptor alpha subunit
- IL6R → Interleukin-6 receptor
- IL8RA → Interleukin 8 receptor, alpha
- IL9R → Interleukin-9 receptor
- ILD → Interstitial lung disease
- ILLUMINATE → Investigation Of Lipid Level Management To Understand Its Impact In Atherosclerotic Events
- ILLUMINATE trial → ILLUMINATE Trial
- ILLUSTRATE → Investigation Of Lipid Level Management Using Coronary Ultrasound To Assess Reduction Of Atherosclerosis By Cetp Inhibition And Hdl Elevation
- IMAGES → Intravenous Magnesium Efficacy In Stroke
- IMAGINE reported: early ACE inhibitor therapy in low risk CABG patients associated with worse early outcomes → Special:Badtitle/NS100:IMAGINE reported: early ACE inhibitor therapy in low risk CABG patients associated with worse early outcomes
- IMI → Innovative Medicines Initiative
- IMPACT → Integrilin To Manage Platelet Aggregation To Prevent Coronary Thrombosis International Mexiletine Or Placebo Antiarrhythmic Coronary TrialInternational Multiple Sclerosis Secondary Progressive Avonex Controlled Trial
- IMPACT-HF → Initiation Management Predischarge: Process For Assessment Of Carvedilol Therapy In Heart Failure
- IMPACT II → Integrilin To Minimise Platelet Aggregation And Coronary Thrombus - II
- IMPROVE-CHF → Improved Management Of Patients With Congestive Heart Failure
- IMPROVEDD → IMPROVEDD VTE risk score
- IMPROVEDD risk score → IMPROVEDD risk score calculator
- IMPROVEDD risk score calculator → IMPROVEDD VTE risk score
- IMPROVEDD score → IMPROVEDD VTE risk score
- IMPROVED score → IMPROVEDD risk score calculator
- IMPROVE Score Calculator → IMPROVE risk score calculator
- IMPROVE and IMPROVED → IMPROVE and IMPROVEDD scores for venous thromboembolism
- IMPROVE associative score for VTE → IMPROVE score for venous thromboembolism#IMPROVE Associative Score for VTE
- IMPROVE predictive score for VTE → IMPROVE score for venous thromboembolism#IMPROVE Predictive Score for VTE
- IMPROVE risk score → IMPROVE score
- IMPROVE risk score calculator → IMPROVE VTE risk score
- IMPROVE risk score for VTE → IMPROVE score for venous thromboembolism
- IMPROVE risk score for bleeding → IMPROVE bleeding risk score
- IMPROVE risk score for venous thromboembolism → IMPROVE score for venous thromboembolism
- IMPROVE score → IMPROVE VTE risk score